ALGN ALIGN TECHNOLOGY INC Insider Trading

CFO Morici sells 7,969 shares of ALGN at $189.31 (Feb 18), reducing stake 49.2% to 8,237 shares post-transaction

John Morici, EVP and Chief Financial Officer, executed a substantial sale of 7,969 shares at $189.31, representing a reduction of nearly half his pre-transaction holdings from 16,206 to 8,237 shares. The transaction occurred when ALGN was trading near record levels, within 8.3% of its 52-week high of $207.19, following strong 30-day (+11.8%) and 90-day (+33.3%) gains. For a CFO overseeing a $13.6B market-cap company with a P/E of 36.06, a large proportional reduction in personal holdings warrants investor attention, particularly given the company's modest 3.5% annual revenue growth relative to its elevated valuation multiple.

CEO Joseph M. Hogan buys 7,576 shares of ALGN at $131.49; prior two ALGN purchases posted 90d returns +47.9% and +43.8%.

Joseph M. Hogan, President and CEO, purchased 7,576 shares at $131.49 on 2025-08-01, expanding his holdings by 4.3% to 184,945 shares post-transaction. The timing warrants investor attention: his two prior open-market purchases of ALGN, executed in October and November 2023, both delivered strong 90-day returns of +47.9% and +43.8% respectively, establishing a pattern of well-timed entry points at this ticker. Notably, this buy occurs as the stock trades -46.9% from its 52-week high and -30.7% over the past 30 days, contrasting sharply with his prior transaction track record. The company's current fundamentals remain solid: $979.3M in quarterly revenue, $93.2M in net income, and a P/E of 24.16, suggesting the CEO's purchase reflects confidence in near-term recovery rather than fundamental deterioration.

EVP Julie Ann Coletti buys 42 ALGN shares at $109.66; stock down 30.7% in 30 days

EVP Coletti acquired 42 shares of ALIGN TECHNOLOGY at $109.66, a modest transaction adding only $4,605.66 to her holdings and representing a +0.6% increase in her position. The timing of this purchase occurs within a sharp downturn: the stock has declined 30.7% over 30 days and sits 46.9% below its 52-week high of $257.17, despite the company posting solid recent fundamentals with $979.3M in quarterly revenue and $93.2M in net income. The small share count acquired relative to her substantial existing holdings (7,110 shares post-transaction) and the modest absolute dollar amount suggest this is a routine personal account activity rather than a material conviction statement about valuation or direction.

Director Larkin C Raymond Jr. buys 6,500 shares of ALGN at $235.33; holdings rise to 23,597 shares (+38.0%)

Director Larkin C Raymond Jr. purchased 6,500 shares at $235.33 on 2024-08-15, increasing his position by 38.0% from 17,097 to 23,597 shares and committing $1,529,645.00 to the purchase. The transaction occurred at a price $4.68 below the current market level of $240.01, and the stock has declined 36.0% from its 52-week high of $374.90, creating a wider margin-of-safety window than recent prices. This open-market buy by a director—a meaningful accumulation in absolute share terms—occurs in the context of a company trading at a 40.14 P/E multiple with modest annual revenue growth of 3.4% against a $1.0B quarterly revenue base, warranting observation of whether this represents a pattern of insider accumulation or a discrete transaction response to current valuation.